Non-surgical potentially reversible dementias;Demencias potencialmente reversibles no quirúrgicas

Revista de Neurologia

Volumn 40, Issue 1, 2005, Pages 54-60

  Barquet Platon E I ^a   Mercado Pimentel, R ^a   Ortiz Velazquez R I ^a   Cardona Cabrera, S ^a   Otero Siliceo, E ^a   Santos Franco, Jorge Arturo ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Reversible dementias; Symptomatic dementias

Indexed keywords

ALCOHOL; AMPHOTERICIN B; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BETHANECHOL; CALCIUM; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYANOCOBALAMIN; FLUCYTOSINE; GLUCOSE; HYPNOTIC AGENT; INSULIN; ISONIAZID; LEVOTHYROXINE; NEUROLEPTIC AGENT; NICOTINIC ACID; ORAL ANTIDIABETIC AGENT; OXYBUTYNIN; PENICILLAMINE; PENICILLIN G; PREDNISONE; PROPRANOLOL; PYRAZINAMIDE; PYRIDOXINE DERIVATIVE; RIFAMPICIN; SODIUM; THIAMINE; UNINDEXED DRUG;

AGE; AGED; ALZHEIMER DISEASE; CHRONIC DISEASE; CHRONIC HEPATITIS; CHRONIC LUNG DISEASE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CRYPTOCOCCOSIS; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DIABETES MELLITUS; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPOCALCEMIA; HYPOGLYCEMIA; HYPOKALEMIA; HYPONATREMIA; INCIDENCE; KIDNEY FAILURE; LABORATORY TEST; LIFE EXPECTANCY; LIVER CIRRHOSIS; LUMBAR PUNCTURE; METABOLIC DISORDER; MULTIINFARCT DEMENTIA; NEUROSYPHILIS; NUTRITIONAL DEFICIENCY; OBSERVATION; PARATHYROID DISEASE; POSITRON EMISSION TOMOGRAPHY; PSEUDODEMENTIA; REVIEW; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; THIAMINE DEFICIENCY; THYROID DISEASE; TUBERCULOSIS; URINARY TRACT INFECTION; WESTERN BLOTTING; WILSON DISEASE; DISEASE COURSE; METABOLISM; NEUROSURGERY; PATHOPHYSIOLOGY;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DEMENTIA; DISEASE PROGRESSION; HUMANS; NEUROSURGICAL PROCEDURES;

EID: 24344435613     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4001.2003581     Document Type: Review

References (36)

1. Piccini C, Bracco L, Armanducci L. Treatable and reversible dementias: an update. J Neurol Sci 1998; 153: 172-81.
2. Nitrini R, Mathias S, Caramelli P. Evaluation of 100 patients with reversible dementia in Sao Paulo, Brazil: correlation with socioeconomic status and education. Alzheimer Dis Assoc Disord 1995; 9: 146-51.
3. Pasquier F. Differential diagnosis of Alzheimer's disease. Rev Prat 1998; 48: 1906-11.
4. Mangino M, Middlemiss C. Alzheimer's disease: preventing and recognizing a misdiagnosis. Nurse Pract 1997; 22: 58-70.
5. Corey-Bloom J, Thai LJ, Galasko D, Folstein M, Drachman D, Raskind M, et al. Diagnosis and evaluation of dementia. Neurology 1995; 45: 211-8.
6. Chiu H, Zhang Q. Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology's Practice Parameters. Neurology 1997; 49; 925-35.
7. Small GW. Alzheimer's disease and other dementing disorders. In Kaplan H, Saddock B, eds. Comprehensive textbook of Psychiatry. Baltimore: Williams and Wilkins; 1989. p. 2028-31.
8. Small SA, Mayeux R. Delirium and dementia. In Rowland LP, ed. Merrit's Neurology. 10 ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 3-7.
9. Small SA, Mayeux R. Alzheimer disease and related dementias. In Rowland LP, ed. Merrit's Neurology. 10 ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 633-41.
10. Fleming KC, Adams AC, Petersen RC. Dementia: diagnosis and evaluation. Mayo Clin Proc 1995; 70: 1093-107.
11. Pérez-Martínez DA, De Toledo-Heras M, Saiz-Díaz RA. Demencias reversibles en consulta neurológica extrahospitalaria. Rev Neurol 1999; 29: 425-8.
12. Pennypacker LC, Allen RH, Kelly JP. High prevalence of cobalamin deficiency among elderly outpatients. J Am Geriatr Soc 1992; 40: 1197-1204.
13. Horvath TB, Siever LJ, Mohs RC, Davis K. Organic mental syndromes and disorders. In Kaplan H, Saddock B, eds. Comprehensive textbook of Psychiatry. Baltimore: Williams and Wilkins; 1989. p. 599-641.
14. Freters S, Bregman H, Gold S. Prevalence of potentially reversible dementias and actual reversibility in a memory clinic cohort. CMAJ 1998; 159: 657-62.
15. Farina E, Pomati S, Mariani C. Observations on dementias with possibly reversible symptoms. Aging 1999; 11: 323-8.
16. Clarfield AM. The reversible dementias: do they reverse?. Ann Intern Med 1988; 109: 476-86.
17. Siu AL. Screening for dementia and investigating causes. Ann Intern Med 1991; 115: 122-32.
18. Frank C. Dementia Workup. Deciding on laboratory testing for the elderly. Can Fam Physician 1998; 4: 1498-5.
19. Small GW, Rabins PV, Barry PP, Buckholtz NS, De Kosky ST, Ferris SH, et al. Diagnosis and treatment of Alzheimer disease and related disorders. JAMA 1997; 278: 1363-71.
20. Geldmacher DS, Whitehouse PJ. Differential diagnosis Alzheimer's disease. Neurology 1997; 48: 2-9.
21. Royall DR, Polk M. Dementias that present with and without posterior cortical features: an important clinical distinction. J Am Geriatr Soc 1998; 46: 98-105.
22. Robinson BE. Guideline for the initial evaluation of the patient with memory loss. Geriatrics 1997; 52: 30-9.
23. Stanhelin HB. Dementia: diagnosis and treatment. Schweiz Med Wochenschr; 1997; 127: 1789-95.
24. Farlow MR. Dementia. In Biller J, ed. Practical Neurology. Philadelphia: Lippincott Raven; 1997. p. 461-9.
25. Bird TD. Amnesia y demencia. In Fauci AS, Branwald E, Isselbacher KJ, Wilson JD, Martín JB, Kasper DL, et al, eds. Harrison, Principios de Medicina Interna. México: McGraw-Hill Interamericana; 1998. p. 164-72.
26. López-Pousa S. Síndromes demenciales causados por infecciones. In Alberca R, López-Pousa S, eds. Enfermedad de Alzheimer y otras demencias. Madrid: Médica Panamericana; 1998. p. 635-57.
27. Adams RD, Victor M, Ropper AH. Dementia and the amnesic (Korsakoff) syndrome. In Adams RD, Victor M, Ropper AH, eds. Principles of Neurology. New York: McGraw-Hill; 1997. p. 417-34.
28. Adams RD, Victor M, Ropper AH. The acquired metabolic disorders of the nervous system. In Adams RD, Victor M, Ropper AH, eds. Principles of Neurology. New York: McGraw-Hill; 1997. p. 1108-37.
29. Manubens JM. Demencia y enfermedades endocrinas. In Alberca R, López-Pousa S, eds. Enfermedad de Alzheimer y otras demencias. Madrid: Médica Panamericana; 1998. p. 663-75.
30. Manubens JM. Demencias, déficit vitamínicos y nutricionales. In Alberca R, López-Pousa S, eds. Enfermedad de Alzheimer y otras demencias. Madrid: Médica Panamericana; 1998. p. 677-87.
31. Clarfield AM, Friedland RP, Hedera P. Reversible dementia (correspondence). Neurology 1995; 45: 601.
32. Beal MF, Martín JB. Enfermedades nutricionales y metabólicas del sistema ] nervioso. In Fauci AS, Branwald E, Isselbacher KJ, Wilson JD, Martín JB, Kasper DL, et al, eds. Harrison, Principios de Medicina Interna. México DF: McGraw-Hill Interamericana; 1998. p. 2792-9.
33. Guerrini R, Belmonte A, Canapicchi R, Casalini C, Perucca E. Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment. Epilepsia 1998; 39: 27-32.
34. Fossan G. Dementia -Where are we today? Tidsskr Nor Laegeforen 1998; 115: 1233-5.
35. Winokur G, Clayton P. The medical basis of Psychiatry. Philadelphia: WB Saunders; 1994.
36. Blazer D, Hughes DC, George LK. The epidemiology of dementia in an elderly community population. Gerontologist 1987; 27: 281-7.